Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse ERK1 + ERK2 ELISA Kit (AC3447)
Cat.#: ASET-2036
Specifications
Description Mouse ERK1 + ERK2 ELISA Kit allows for the in vitro quantitative determination of mouse ERK1 + ERK2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.469 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.781-50 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1583 Chicken Adiponectin ELISA Kit (AC2994) Quantitative inquiry ASET-1110 Mouse ABCA1 ELISA Kit (AC2521) Quantitative inquiry ASET-1896 Rabbit Neurotrophin 3 ELISA Kit (AC3307) Quantitative inquiry ASET-1373 Human Laminin 2 alpha ELISA Kit (AC2784) Quantitative inquiry ASET-2497 Mouse Midkine ELISA Kit (AC3908) Quantitative inquiry ASET-1517 Mouse PSD95 ELISA Kit (AC2928) Quantitative inquiry ASET-2178 Mouse Aldh1a7 ELISA Kit (AC3589) Quantitative inquiry ASET-2241 Mouse Robo4 ELISA Kit (AC3652) Quantitative inquiry ASET-2333 Human S100A7L2 ELISA Kit (AC3744) Quantitative inquiry ASET-2460 Human SHC ELISA Kit (AC3871) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket